Every recall we track for ACCORD HEALTHCARE, INC. — 106 in all — plus the complaints and injury reports the public filed about them.
Accord Healthcare recalls 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls specific levothyroxine sodium tablets (100 mcg) with subpotent drug content. These tablets may not provide the intended thyroid hormone levels, potentially causing health issues if used without medical supervision.
Accord Healthcare recalls 90-count and 1000-count Levothyroxine Sodium Tablets (175 mcg) due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets with subpotent drug risk. Affected lots expire 09/30/2026. Consumers should contact pharmacy for guidance.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact their doctor for alternative treatment options.
Accord Healthcare recalls 90-count Levothyroxine tablets (300 mcg) due to subpotent drug content. This may result in insufficient thyroid hormone levels. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 90-count and 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide the correct dosage, risking health issues. Return or contact for details.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug content. This may cause insufficient thyroid hormone levels. Affected products have specific lot numbers and expiration dates.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets with subpotent drug risk. Affected lots expire by 2026. Stop using if you have these specific batches.
Accord Healthcare recalls 90-count and 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide the intended thyroid hormone dose. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 90-tablet Levothyroxine Sodium 300 mcg bottles due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact pharmacy for guidance.
Accord Healthcare recalls Levothyroxine Sodium Tablets (88 mcg) due to subpotent content. This may lead to insufficient thyroid hormone levels. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This may result in ineffective treatment. Check NDC 16729-451-17 and lot numbers for affected products.
Accord Healthcare recalls 25 mcg levothyroxine tablets due to subpotent drug levels. This may cause ineffective treatment. Check NDC 16729-447-17 and lot D2400679 for affected products.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. These tablets may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This means the medication may not provide the intended thyroid hormone dose, potentially causing treatment failure. Consumers should contact their doctor for guidance.
Accord Healthcare recalls 50 mcg levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Check NDC 16729-448-15 and lot #D2300087 for affected products.
Accord Healthcare recalls 25 mcg levothyroxine tablets with assay below approved levels. This may cause ineffective treatment. Return or consult doctor for replacement.
Accord Healthcare recalls 1000-count levothyroxine tablets due to assay below approved levels. This may result in insufficient thyroid hormone delivery. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-bottle supply of 25 mcg levothyroxine tablets due to subpotent content. This may lead to insufficient thyroid hormone levels. Consumers with prescriptions should contact their doctor.
Accord Healthcare recalls 1000 bottles of Levothyroxine Sodium Tablets (50 mcg) due to subpotent content. This may lead to insufficient thyroid hormone levels. Consumers with prescriptions should contact their doctor.
Accord Healthcare recalls 90-bottle Levothyroxine Sodium Tablets (112 mcg) due to subpotent levels. This may not provide enough thyroid hormone. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-bottle supply of Levothyroxine Sodium Tablets (88 mcg) due to subpotent levels. This may not provide adequate thyroid hormone. No remedy specified in recall notice.
Accord Healthcare recalls Cinacalcet 30mg tablets due to nitrosamine impurity exceeding safe limits. Affected lots from 2021-2025 may pose health risks. Consumers should check product details and contact manufacturer.
Accord Healthcare recalls cisplatin injection vials due to failed impurities and degradation specifications. This could cause serious injury if used improperly. Patients should contact their doctor for guidance.
Accord Healthcare recalls Dodex Injectable (Cyanocobalamin) vials with subpotent drug results. Affected lots expire June 2024. No remedy specified in official notice.
Accord Healthcare recalls Atropine Sulfate Injection vials due to fiber particles. This may cause serious injury if injected. Stop using immediately and contact the manufacturer.
Accord Healthcare recalls 10 vials of Bivalirudin 250mg injection due to fiber particles. This may cause serious injury if injected. Stop using and contact for return.
Accord Healthcare recalls Dodex Injectable Cyanocobalamin Injection due to sub-potent drug levels at 9-month testing. This may affect treatment effectiveness. Consumers should check product details and contact manufacturer for guidance.
Accord Healthcare is recalling Pravastatin Sodium Tablets 20mg (90-count) manufactured in India with specific batch numbers due to FDA inspection deviations. Consumers should check their product details and contact the company for instructions.
Accord Healthcare recalls 10mg Pravastatin tablets (NDC 16729-008-15 and 16729-008-16) after FDA inspection found manufacturing deviations. Consumers should check their bottles for batch numbers and expiration dates.
Accord Healthcare recalls 1 mg Finasteride tablets due to FDA inspection findings. Products with NDC 16729-089-10 or 16729-089-15 may be affected. No specific remedy provided in recall notice.
Accord Healthcare recalls rOPINIRole 0.5mg tablets manufactured for FDA inspection deviations. Products with specific batch numbers and expiration dates are affected. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 100-count and 1,000-count Doxazosin 4mg tablets (NDC 16729-213-01 and 16729-213-17) following FDA inspection for CGMP deviations. Consumers should check batch numbers and expiration dates.
Accord Healthcare is recalling 30-count and 100-count Aripiprazole 5mg tablets (NDC 16729-279-10 and 16729-279-01) after FDA inspection found manufacturing deviations. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 5mg Finasteride tablets due to FDA inspection finding CGMP deviations. Products with specific NDC codes and batch numbers are affected. Consumers should check their bottles for the listed identifiers.
Accord Healthcare recalls rOPINIRole 4mg tablets (NDC 16729-237-01) manufactured in India following FDA inspection. Products may have CGMP deviations.
Accord Healthcare recalls 30mg Aripiprazole Tablets (NDC 16729-283-10 and 16729-283-01) after FDA inspection found manufacturing deviations. Consumers should check product labels for batch numbers and expiration dates.
Accord Healthcare recalls 25 vials of Glycopyrrolate Injection due to FDA inspection finding CGMP deviations. This medication is prescription-only and may be unsafe if used after the recall date.
Accord Healthcare recalls 4 mg Glimepiride Tablets USP (NDC 16729-003-01 and 16729-003-16) after FDA inspection found manufacturing deviations. Consumers should check product details and contact the manufacturer.
Accord Healthcare recalls specific batches of Clopidogrel 75mg tablets (Rx only) manufactured for FDA compliance issues. Affected products include 30-count, 90-count, and 500-count bottles with listed NDC and batch numbers. Consumers should check their product details and contact the manufacturer for guidance.
Accord Healthcare recalls phenylephrine injection vials produced with FDA inspection deviations. This recall affects specific batches and requires immediate action to ensure safety.
Accord Healthcare recalls Vigabatrin oral solution (500mg) due to FDA inspection finding manufacturing deviations. Affected products include specific NDC and batch numbers. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 60-count Dofetilide Capsules (125 mcg) manufactured for FDA inspection deviations. This prescription-only medication may pose risks if not handled properly.
Accord Healthcare recalls 500 mcg Dofetilide Capsules (Rx only) manufactured in India with FDA inspection deviations. Consumers should contact the manufacturer for details.
Accord Healthcare is recalling 20 mg Aripiprazole tablets from specific batches after FDA inspection found manufacturing deviations. Consumers should check product details and contact the company for guidance.
Accord Healthcare recalls 100-count BusPIRone Hydrochloride Tablets 15mg (Rx only) manufactured in India following FDA inspection. Products may have CGMP deviations.
Accord Healthcare is recalling 5mg Rosuvastatin tablets (NDC 16729-284-15 and 16729-284-17) after FDA inspection found manufacturing deviations. Consumers should check their bottles for specific batch numbers and expiration dates.
Accord Healthcare is recalling 10mg Rosuvastatin tablets (NDC 16729-285-15 and 16729-285-17) after FDA inspection found manufacturing deviations. Consumers should not use these products.
Accord Healthcare recalls 25-vial Glycopyrrolate Injection due to FDA inspection finding manufacturing deviations. This medication is prescription-only and may be unsafe if used as intended.
Accord Healthcare is recalling 2mg Aripiprazole tablets (NDC 16729-278-10 and 16729-278-01) after FDA inspection found manufacturing deviations. Consumers should contact the manufacturer for details.
Accord Healthcare is recalling 20 mg Atorvastatin Calcium Tablets USP (Rx only) manufactured in India with FDA inspection deviations. Products may contain unsafe levels of impurities.
Accord Healthcare recalls Rosuvastatin 40mg tablets (NDC 16729-287-10, etc.) after FDA inspection found manufacturing deviations. Consumers should contact the manufacturer for details.
